Risk for PML in Multiple Sclerosis Predicted With Anti-JCV Antibody Index
While an efficacious treatment for relapsing MS, natalizumab is associated with risk of developing progressive multifocal leukoencephalopathy.
Natalizumab exposure is associated with an increased risk of spontaneous abortion for pregnant women with multiple sclerosis.
A vestibular-related rehabilitation program is associated with imrpoved outcomes for patients with multiple sclerosis.
Rituximab was associated with lower discontinuation rates as compared to other disease-modifying treatments in newly diagnosed patients with relapsing-remitting multiple sclerosis.